Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Cell Biology|August 8, 2024
AMPK activation induces RALDH+ tolerogenic dendritic cells by rewiring glucose and lipid metabolismEline C Brombacher, Thiago A Patente, Alwin J van der Ham, et al.
Cell Reports|October 12, 2022
Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITABrett J Hos, Elena Tondini, Marcel G M Camps, et al.
Angiogenesis|May 2, 2025
The VEGF decoy receptor soluble Fms-like tyrosine kinase 1 binds to macrophagesCleo C L van Aanhold, Qing Yong, Lisa Landman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.
The Journal of Experimental Medicine|April 26, 2006
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyEric A Reits, James W Hodge, Carla A Herberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpzNatasja G de Groot, Corrine M C Heijmans, Yvonne M Zoet, et al.
Blood|January 20, 2007
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.
Proteomics|December 19, 2017
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell SurfaceHelena M Bijen, Chopie Hassan, Michel G D Kester, et al.
European Journal of Immunology|December 4, 2020
PAKC: A novel panel of HLA class I antigen presentation machinery knockout cells from the same genetic originAntonius A de Waard, Tamara Verkerk, Marlieke L M Jongsma, et al.
Blood|January 6, 2017
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.
Pageof 11